Header image

Session G: HCV Diagnosis and Linkage to Care

Thursday, September 7, 2017
9:00 AM - 11:10 AM
Manhattan Ballroom

Speaker

Attendee912

Novel Diagnostics for HCV Infection: Where are we Now and Where are we Headed?

9:00 AM - 9:25 AM

Speaker Presentation

Video Presentation

Biography

Attendee550

Novel Strategies to Enhance Testing and Linkage to HCV Care and Treatment

9:25 AM - 9:50 AM

Speaker Presentation

Video Presentation

Biography

Attendee320

How to Work with People who Inject Drugs in Building Relevant Models of HCV Care?

9:50 AM - 10:15 AM

Speaker Presentation

Video Presentation

Biography

Agenda Item Image
Prof Magdalena Harris
Professor Of Inclusion Health Sociology
London School Of Hygiene & Tropical Medicine

Identity Transformations and other Unexpected Benefits of HCV Treatment: A Review of the Evidence and Reflections for the DAA Era

10:15 AM - 10:40 AM

Speaker Presentation

Video Presentation

Biography

Attendee309

Efficacy and Safety of Sofosbuvir/ Velpatasvir in People with Chronic HCV Infection and Recent Injecting Drug Use: The SIMPLIFY Study

10:40 AM - 10:55 AM

Abstract

Speaker Presentation

Biography

Agenda Item Image
Mrs. Kathleen Ward
Postdoctoral Research Fellow
Columbia University

Randomized Controlled Trial of Cash Incentives or Peer Mentors to Improve HCV Linkage and Treatment among HIV/HCV Coinfected Persons who Inject Drugs: the Champs Study

10:55 AM - 11:10 AM

Abstract

Speaker Presentation

Biography

Footer image
loading